Clinical Characteristics, Anti-hyperglycaemic Treatment Pattern and Target Attainment of Type 2 Diabetes Mellitus Patients in Older Population With or Without Albuminuria in China

Boehringer Ingelheim

Status: Completed

Conditions: Type 2 Diabetes Mellitus

Treatments: Drug: No Treatment

Study type: Observational

Funder types: Industry

Identifiers

NCT03064841

1218.174

Details and patient eligibility

About

This is a multi-centre, cross-sectional, non-interventional study assessing blood glucose target attainment, anti-hyperglycaemic treatment pattern and the clinical characteristics in older outpatients with Type 2 Diabetes Mellitus (T2DM) in hospitals of China. This study is designed to collect information of older T2DM patients in a real life setting

Enrollment: 1,537 patients

Sex: All

Ages: 60+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria

• Patient should fully know and understand the content of consent form, and the patient is willing and able to sign an informed consent form
• Outpatient with confirmed T2DM (According to the American Diabetes Association criteria 2015 [R16-1532])
• Age≥60 years

Exclusion criteria

• Patients with type 1 diabetes mellitus or secondary DM
• Patients who are participating in any other clinical study, including any questionnaire-based study, any interventional study (including diet/counselling based intervention), or any clinical study in which any medications (including Chinese herbal medications) are administered

Trial design

1,537 participants in 1 patient group

Outpatient with confirmed T2DM

Description:

subjects with confirmed T2DM

Treatment:

Drug: No Treatment